Citation Impact
Citing Papers
How cognitive and reactive fear circuits optimize escape decisions in humans
2018 StandoutNobel
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
2020 StandoutScience
Carotenoids: biochemistry, pharmacology and treatment
2016 Standout
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017 Standout
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
2015
A Systematic Review of Healthcare Applications for Smartphones
2012 Standout
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
2008
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
2019
Functional neuroimaging in schizophrenia: diagnosis and drug discovery
2008
Adverse Health Effects of Marijuana Use
2014 Standout
Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus
2014
From Threat to Fear: The Neural Organization of Defensive Fear Systems in Humans
2009 StandoutNobel
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
2010
A neuropeptide S receptor variant associated with overinterpretation of fear reactions: a potential neurogenetic basis for catastrophizing
2010
The Common Traits of the ACC and PFC in Anxiety Disorders in the DSM-5: Meta-Analysis of Voxel-Based Morphometry Studies
2014
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers
2019 Standout
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
2016 Standout
Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings
2013
Psychedelics
2016 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Slow escape decisions are swayed by trait anxiety
2019 StandoutNobel
Clinical applications of hallucinogens: A review.
2016
Neuroimaging predictors of transition to psychosis—A systematic review and meta-analysis
2010
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Association between cannabis use, psychosis, and schizotypal personality disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions
2013
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
Emotional processing in anterior cingulate and medial prefrontal cortex
2010 Standout
Marijuana: Respiratory Tract Effects
2013
Rethinking schizophrenia
2010 StandoutNature
The Neurocircuitry of Fear, Stress, and Anxiety Disorders
2009
Making “bad trips” good: How users of psychedelics narratively transform challenging trips into valuable experiences
2020 Standout
Antidepressant‐like effects of cannabidiol in mice: possible involvement of 5‐HT1Areceptors
2009
The neural basis of psychedelic action
2022 Standout
5‐HT1Areceptors are involved in the cannabidiol‐induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats
2008
The role of iron in brain ageing and neurodegenerative disorders
2014 Standout
Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo
2009
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
2008
Potency of Δ9–THC and Other Cannabinoids in Cannabis in England in 2005: Implications for Psychoactivity and Pharmacology*
2008
Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion
2011
Ayahuasca: Pharmacology, neuroscience and therapeutic potential
2016
Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19
2020
Classical psychedelics for the treatment of depression and anxiety: A systematic review
2019
The integration of negative affect, pain and cognitive control in the cingulate cortex
2011 Standout
Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing
2009
The ecology of human fear: survival optimization and the nervous system
2015
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
2017
Virtualizing the p-ANAPL Library: A Step towards Drug Discovery from African Medicinal Plants
2014
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
2010
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
2018
Real-Time Electronic Ambulatory Monitoring of Substance Use and Symptom Expression in Schizophrenia
2010
Uso terapêutico dos canabinoides em psiquiatria
2010
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
2016
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
2010
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
2016 Standout
Role of Brain Iron Accumulation in Cognitive Dysfunction: Evidence from Animal Models and Human Studies
2013
A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
2021
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
2015
Cannabinoids in health and disease
2007
The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors
2019 Standout
Annual Research Review: Enduring neurobiological effects of childhood abuse and neglect
2016 Standout
Neural Circuitry of Impaired Emotion Regulation in Substance Use Disorders
2016
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
2008
The Endocannabinoid System and the Brain
2012
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of J.A.S. Crippa being referenced
Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
2009
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
2011
Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus
2010
Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
2010
Regional gray matter abnormalities in panic disorder: A voxel-based morphometry study
2008
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol
2009
Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users
2014
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
2009
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
2010
Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
2006
Reliability and validity of a Portuguese version of the Young Mania Rating Scale
2005